CorMedix, Inc. (CRMD)
8.28
+0.08
(+0.98%)
USD |
NASDAQ |
Aug 24, 16:00
8.28
0.00 (0.00%)
Pre-Market: 08:12
CorMedix Debt to Equity Ratio : 0.315 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.315 |
| March 31, 2026 | 0.3315 |
| December 31, 2025 | 0.3674 |
| September 30, 2025 | 0.0117 |
| June 30, 2025 | 0.002 |
| March 31, 2025 | 0.0041 |
| December 31, 2024 | 0.0061 |
| September 30, 2024 | 0.0095 |
| June 30, 2024 | 0.0129 |
| March 31, 2024 | 0.0109 |
| December 31, 2023 | 0.0095 |
| September 30, 2023 | 0.0084 |
| June 30, 2023 | 0.015 |
| March 31, 2023 | 0.0143 |
| December 31, 2022 | 0.0146 |
| September 30, 2022 | 0.0148 |
| June 30, 2022 | 0.014 |
| March 31, 2022 | 0.0149 |
| December 31, 2021 | 0.0147 |
| September 30, 2021 | 0.0137 |
| June 30, 2021 | 0.0127 |
| March 31, 2021 | 0.0125 |
| December 31, 2020 | 0.0234 |
| September 30, 2020 | 0.0305 |
| June 30, 2020 | 0.0002 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0002 |
| December 31, 2019 | 0.0002 |
| September 30, 2019 | 0.0002 |
| June 30, 2019 | 0.4091 |
| March 31, 2019 | 0.3889 |
| December 31, 2018 | 1.241 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | -5.416 |
| March 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Innoviva, Inc. | 0.2187 |
| Zevra Therapeutics, Inc. | 0.0069 |
| Filana Therapeutics, Inc. | 0.00 |
| Eloxx Pharmaceuticals, Inc. | 0.00 |
| Cannabis Global, Inc. | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 904.05M |
| Total Liabilities (Quarterly) | 443.22M |
| Shareholders Equity (Quarterly) | 460.83M |
| Current Ratio | 2.564 |
| Net Debt Paydown Yield | -4.75% |